Position
Chief Business Officer
Company
Cerenome, Inc.
HoustonManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalHealth DiagnosticsDescription
Cerenome, Inc. announced the appointment of Ronald A. Andrews as Chief Business Officer, effective November 9, 2026
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Bristol Myers Squibb Appoints Cristian Massacesi as Head of R&D (November 15, 2026)
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- Jazz Pharmaceuticals Announces Transition in Leadership (October 9, 2026)
- Absci Corporation Appoints Gerry Muhle as Chief Commercial Officer (November 12, 2026)
- Nurix Therapeutics Appoints Arati V. Rao, M.D., as Chief Medical Officer (November 12, 2026)
- GH Research PLC Appoints Vanina Popova as Chief Development Officer (November 13, 2026)
Who to call at Cerenome, Inc., and when
A new leader at Cerenome, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cerenome, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cerenome, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cerenome, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cerenome, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cerenome, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.